FDMT
4D Molecular TherapeuticsFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-21
+
Peers tracked
12
U.S. public peers
Grade Position
Below peers
vs peer average
FDMT vs peer average
15/100
FDMT vs. peer average (F vs. C)
Grade spread
A 3 · B 2 · C 1 · D 5
Graded peers loaded
Coverage
11 graded
92% of tracked
Peer overview
RGNX is the first available peer comparator.
AAV platform developer; relevant for platform licensing and commercialization precedent.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
FDMT
4D Molecular Therapeutics
RGNX
REGENXBIO
Grade
F
A
Momentum
89
98
Value
41
41
Sentiment
0
58
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive
Grade position vs RGNX
FDMT / RGNX
Grade Position
Below peers
FDMT vs. peer average (F vs. C)
15/100
Momentum
89
RGNXValue
41
FDMTSentiment
0
RGNXRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs FDMT
RGNX is the first peer returned for this comparison set.